{
    "code": "01031167",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01031167",
    "time": "2019-02-15 04:15:33",
    "許可證字號": "衛署藥製字第031167號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/12\/21",
    "發證日期": "77\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY00103116709",
    "中文品名": "&quot;聯邦&quot;優霸注射液（泰百黴素）",
    "英文品名": "URIBRA INJECTION (TOBRAMYCIN) &quot;UNION&quot;",
    "適應症": "綠膿桿菌、變形桿菌、大腸桿菌、克雷白氏桿菌、檸檬酸桿菌、普洛維頓斯桿菌、葡萄球菌、丁族鏈球菌等所致之中樞神經系統、胃腸道、生殖泌尿道、下呼吸道、皮膚、骨骼及軟組織重度感染症",
    "劑型": "270注射劑",
    "包裝": "2,4,10公撮，100支以下小瓶",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "TOBRAMYCIN(SULFATE)"
    ],
    "限制項目": "01國　產 1G不得製造",
    "申請商名稱": "1700702200  聯邦化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1700702300  聯邦化學製藥股份有限公司",
        "製造廠廠址": "新北市蘆洲區正和街１９號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30042000113 人用醫藥製劑，含胺基配醣體類抗生素者（含鏈黴素或其衍生物；其鹽類者除外）Medicaments, containing aminoglycosides (excluding streptomycins or their derivatives; salts thereof), for human use",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812109910",
            "成分名稱": "TOBRAMYCIN (SULFATE)",
            "含量描述": "",
            "含量": "40.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "031167_仿單_103.04.01-103-04-25.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01031167&Seq=002&Type=9"
        }
    ]
}